Fabry Disease

Medications for Fabry Disease

About Fabry Disease: Storage disease because of lack of ceramide trihexosidase.

The following list of medications come in some way associated with, or utilized in the treating this particular condition.

Drug title	Rx / OTC	Pregnancy	CSA	Reviews	Rating
Fabrazyme	Rx	B	N	Add review	0.0
Generic title: agalsidase beta systemic Drug category: lysosomal enzymes For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information

agalsidase beta	Rx	B	N	Add review	0.0
Generic title: agalsidase beta systemic Brand title: Fabrazyme Drug category: lysosomal enzymes For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph

Galafold	Rx		N	Add review	0.0
Generic title: migalastat systemic Drug class: mixed metabolic brokers For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information

migalastat	Rx		N	Add review	0.0
Generic title: migalastat systemic Brand title: Galafold Drug class: mixed metabolic brokers For users: dosage, interactions, For professionals: a z Drug Facts, AHFS DI Monograph

Rx	prescription-only
OTC	Over the Counter
Rx/OTC	Prescription or Over The Counter
Away Tag	This medication might not be approved by the FDA for treating the particular condition.

Pregnancy Category
A	sufficient and well-controlled studies have failed to present a risk to the fetus within the first trimester of pregnancy (and there`s no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in elderly women.
C	Animal research studies have shown an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks.
D	There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in elderly women clearly outweigh potential rewards.
N	FDA has not classified the medication.

Controlled Substances Act (CSA) Schedule
N	isn`t subject to the Controlled Substances Act.
Inch	Has a higher possibility of misuse. Has no currently accepted medical use in treatment in the USA. There`s just a lack of accepted safety for use under medical supervision.
2	Has a higher possibility of misuse. Includes a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Psychotherapy can lead to severe emotional or physical dependence.
3	Has a possibility for abuse less than individuals in schedules 1 and 2 two. Includes a currently accepted medical use in treatment in the USA. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence.
4	Has a low potential for abuse in accordance with individuals in program 3. It`s a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence relative to individuals in program 3.
5	Has a low potential for abuse in accordance with individuals in program 4. Includes a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence.

Alcohol
X	Interacts with Alcohol.

Always ask your physician to make sure the information pertains to some circumstances.